Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

Standard

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. / Kuehn, Thorsten; Bauerfeind, Ingo; Fehm, Tanja; Fleige, Barbara; Hausschild, Maik; Helms, Gisela; Lebeau, Annette; Liedtke, Cornelia; von Minckwitz, Gunter; Nekljudova, Valentina; Schmatloch, Sabine; Schrenk, Peter; Staebler, Annette; Untch, Michael.

In: LANCET ONCOL, Vol. 14, No. 7, 7, 2013, p. 609-618.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kuehn, T, Bauerfeind, I, Fehm, T, Fleige, B, Hausschild, M, Helms, G, Lebeau, A, Liedtke, C, von Minckwitz, G, Nekljudova, V, Schmatloch, S, Schrenk, P, Staebler, A & Untch, M 2013, 'Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.', LANCET ONCOL, vol. 14, no. 7, 7, pp. 609-618. <http://www.ncbi.nlm.nih.gov/pubmed/23683750?dopt=Citation>

APA

Kuehn, T., Bauerfeind, I., Fehm, T., Fleige, B., Hausschild, M., Helms, G., Lebeau, A., Liedtke, C., von Minckwitz, G., Nekljudova, V., Schmatloch, S., Schrenk, P., Staebler, A., & Untch, M. (2013). Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. LANCET ONCOL, 14(7), 609-618. [7]. http://www.ncbi.nlm.nih.gov/pubmed/23683750?dopt=Citation

Vancouver

Bibtex

@article{0e9889d4e51146d99a7e77503bd9602c,
title = "Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.",
abstract = "The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.",
author = "Thorsten Kuehn and Ingo Bauerfeind and Tanja Fehm and Barbara Fleige and Maik Hausschild and Gisela Helms and Annette Lebeau and Cornelia Liedtke and {von Minckwitz}, Gunter and Valentina Nekljudova and Sabine Schmatloch and Peter Schrenk and Annette Staebler and Michael Untch",
year = "2013",
language = "English",
volume = "14",
pages = "609--618",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "7",

}

RIS

TY - JOUR

T1 - Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

AU - Kuehn, Thorsten

AU - Bauerfeind, Ingo

AU - Fehm, Tanja

AU - Fleige, Barbara

AU - Hausschild, Maik

AU - Helms, Gisela

AU - Lebeau, Annette

AU - Liedtke, Cornelia

AU - von Minckwitz, Gunter

AU - Nekljudova, Valentina

AU - Schmatloch, Sabine

AU - Schrenk, Peter

AU - Staebler, Annette

AU - Untch, Michael

PY - 2013

Y1 - 2013

N2 - The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.

AB - The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.

M3 - SCORING: Journal article

VL - 14

SP - 609

EP - 618

JO - LANCET ONCOL

JF - LANCET ONCOL

SN - 1470-2045

IS - 7

M1 - 7

ER -